Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Agbio Receives SBIR Grant

NEW YORK, Aug 29 – Third Wave Agbio said Wednesday it had received a $100,000 grant from the US Food and Drug Administration to develop DNA-based tools for detecting genetically modified organisms. 

The grant comes from the FDA’s Phase I Small Business Innovation Research program. 

"As the reliance on genetically engineered crops continues to increase, the ability to identify and distinguish them from unmodified crops is a major consideration for grain producers, grain handlers, food manufacturers and consumers" Glen Donald, CEO of Third Wave Agbio, said in a statement.

"Our research will focus on filling the need to easily detect genetically engineered crops,” he added.

Third Wave Agbio of Madison, Wis., uses Third Wave Technology’s Invader system for detecting genetic sequences and SNPs of interest.

Third Wave Technology owns a “significant” stake of privately held Third Wave Agbio, which has the exclusive license to the Invader technology for plant and animal agricultural applications, the company said.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.